Biosimilars Market Worth 23.63 Billion USD by 2023

https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg?p=captionPUNE, India, April 6, 2018 /PRNewswire/ -- According to a new market research report "Biosimilars Market by Product (Recombinant Non-Glycosylated Proteins (Insulin, rHGH, Interferon), Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)), Manufacturing Type (In-house, Contract),...